AUSTRALIA
info@sudapharma.com
Facebook
Twitter
Linkedin
YouTube
+61 8 6142 5555
Menu
About Us
Snapshot
Our People
Leadership Team
Management Team
Scientific Advisory Board Members
Corporate Governance and Charters
Technology
Products
Zolpimist™ – Treatment for Insomnia
R&D
Anagrelide: Treatment for Cancer
Sumatriptan: Treatment for Migraine
Cannabinoids (CBD)
Ondansetron : Nausea
Sildenafil : Erectile Dysfunction/PAH
Midazolam: Treatment for Epilepsy & Anxiety
Investors
ASX Announcements
Presentations
Analyst Reports
Media
Contact Us
29 Mar 21
Newsletter March 2021
07 Oct 20
SUDA Newsletter Oct 2020
